U.S. High-Throughput Genomic Screening For Preventive Healthcare Market Size & Outlook
The high-throughput genomic screening for preventive healthcare market in the United States is expected to reach a projected revenue of US$ 925.4 million by 2033. A compound annual growth rate of 11.8% is expected of the United States high-throughput genomic screening for preventive healthcare market from 2026 to 2033.
- Clinical Diagnostics
- Genetic Testing
- High-Throughput Genomic Screening for Preventive Healthcare Market Outlook
- Genetic Testing